Kazakhstan purchased the ”Gardasil 9” vaccine against HPV: who can get it for free

Photo:depositphotos.com

Tengrinews.kz — Kazakhstan has purchased the Gardasil 9 vaccine against human papillomavirus (HPV). It protects against nine types of HPV that cause cervical cancer and other types of oncological diseases.

How many doses of the HPV vaccine were purchased

According to information provided to the editorial office by SK-Pharmacy LLP, the single distributor purchased 249,952 doses of the American Gardasil 9 vaccine, which protects against human papillomavirus, for 2026.

Note: HPV is a group of more than 200 types of viruses, about 40 of which can be sexually transmitted. Fourteen types are considered oncogenic and may cause cervical cancer and some other types of tumors. The HPV vaccine protects against the most dangerous types of the virus and helps prevent the development of related oncological diseases.

“The first batch — 155,589 doses — arrived in Kazakhstan in June 2026. In accordance with schedules approved by health departments, 92,959 doses have already been shipped to the regions. Delivery of the remaining part of the first batch is planned for August,” SK-Pharmacy explained.

The second batch — 94,000 doses — is expected in October. Its distribution across the regions is planned for November.

Note: Gardasil 9 is a nine-valent vaccine against human papillomavirus (HPV). It protects against nine types of HPV: 6, 11, 16, 18, 31, 33, 45, 52 and 58. The vaccine prevents infection with the most dangerous types of the virus, which cause about 90 percent of cervical cancer cases, and reduces the risk of some other oncological diseases.

Which HPV vaccine Kazakhstan purchased earlier

Kazakhstan began vaccination against human papillomavirus in September 2024. It is included in the National Preventive Vaccination Schedule. Vaccination is voluntary: it is carried out only with the permission of the parents or legal representatives of girls.

Initially, the Ministry of Healthcare purchased the Gardasil 4 vaccine, which protects against four types of HPV.

Note: Gardasil 4 is a quadrivalent vaccine against human papillomavirus (HPV). It protects against HPV types 6, 11, 16 and 18. These types of the virus cause about 70 percent of cervical cancer cases, as well as most cases of genital warts.

The National Center for Public Health of the Ministry of Healthcare told us that initially, the Gardasil 4 vaccine was available to:

girls aged 11 as part of routine vaccination;
girls aged 12–13 as part of catch-up immunization.

Since May 2026, vaccination has also become available to girls aged 14–17, inclusive.

How many girls received the HPV vaccine

According to the National Center, as of early July 2026, 482,000 HPV vaccinations had been administered in Kazakhstan:

265,000 first doses to girls aged 11–13, or 38.1 percent of those eligible to receive it;
175,000 second doses to girls aged 11–13, or 25.2 percent;
42,000 first doses to girls aged 14–17.

The press service said that the current remaining stock of the quadrivalent Gardasil 4 vaccine stands at 126,000 doses.

“Use of the Gardasil 9 vaccine for immunizing the population will begin after the existing remaining stock of Gardasil 4 has been fully used. This will ensure the rational use of purchased vaccines and the continuity of immunization,” the editorial office was told.

The National Center added that Gardasil 9 will be available free of charge to girls aged 11 for routine vaccination and to girls aged 12–13 for catch-up vaccination. They will need to receive two doses.

No final decision has yet been made on whether the vaccine will be available to teenagers aged 14 and older.

Add us to your preferred sources on Google

Add

virus Healthcare health Ministry of Healthcare cancer vaccination vaccine

Kazakhstan buys new vaccine against cancer-causing virus: who will get it for free

How many doses of the HPV vaccine were purchased

Which HPV vaccine Kazakhstan purchased earlier

How many girls received the HPV vaccine